Parkinson's disease is a neurodegenerative disorder characterized by progressive loss of dopaminergic cells in the central nervous system, in particular the substantia nigra, resulting in an unrelenting loss of motor and nonmotor function. Animal models of Parkinson's disease reveal hyperactive neur
Striatal dopaminergic neurons are lost with Parkinson's disease progression
β Scribed by Michelle J. Porritt; Ann E. Kingsbury; Andrew J. Hughes; David W. Howells
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 89 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Increased numbers of dopaminergic neurons are described in the striatum of patients with Parkinson's disease. In postmortem striatal tissue from Parkinson's disease patients with short disease duration (β€8 years), the number of dopaminergic neurons is approximately four times that in patients with long duration (β₯16 years). The data suggest the possibility that the presence of large numbers of these striatal dopaminergic neurons may be harmful and may accelerate the disease process. Alternatively, these neurons may be lost to the disease process. Β© 2006 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract The cause of restless legs syndrome (RLS) is unknown, but an involvement of the dopaminergic system and a possible relation to Parkinson's disease (PD) is suggested by the positive response to dopaminergic treatment. We imaged the striatal dopamine transporter with [^123^I] __N__β(3βiod